Effects of myelopeptides on immune response and morphometrical manifestations of inflammation in experimental penetrating wound of the eye.
Myelopid and MP-1 myelopeptide increase the count of antibody-producing cells, reduced under the effect of injury and standard therapy, and do not modify the suppression of delayed hypersensitivity. Injections of myelopid and MP-3 together with standard drugs optimized the traumatic inflammation processes.
Berkasova
N L
NL
Institute of Ecology and Genetics of Microorganisms, Ural Division of Russian Academy of Sciences, Perm. nlb20mb@yandex.ru
Gavrilova
T V
TV
Shilov
J I
JI
Chereshneva
M V
MV
Medvedeva
S J
SJ
Krochina
N B
NB
Chereshnev
V A
VA
D000818:Animals; D000921:Antibody-Producing Cells / Q000187:drug effects; D001853:Bone Marrow; D005123:Eye / Q000276:immunology*; D015807:Eye Injuries, Penetrating / Q000276:immunology* / Q000473:pathology; D006968:Hypersensitivity, Delayed / Q000276:immunology; D007249:Inflammation / Q000276:immunology* / Q000473:pathology; D008297:Male; D009842:Oligopeptides / Q000494:pharmacology*; D051381:Rats; D017208:Rats, Wistar
D009842:Oligopeptides; C048617:myelopeptides